Haploidentical Allogeneic Transplant With Post-transplant Infusion of Regulatory T-cells

Clinical trial NCT01050764 · TERMINATED

Trial details

NCT number: NCT01050764
Sponsor: Everett Meyer
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Leukemia, Acute Chronic Myelogenous Leukemia (CML)Myelodysplastic Syndrome (MDS)Non-Hodgkin Lymphoma (NHL)Chronic Lymphocytic Leukemia (CLL)Acute Myelogenous Leukemia (AML)Acute Lymphoblastic Leukemia (ALL)

Start date: 2009-06-01
Primary completion: 2012-08-01
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.